EcoDrugPlus

Glutamate Metabotropic Receptor 4

Ensembl ID : ENSSTUG00000038163
Gene Symbol: GRM4
3 Cross references
190 Possible Orthologues:

Glutamate Receptor 1-Like

Ensembl ID : ENSSTUG00000041084
Gene Symbol: LOC115205604
3 Cross references
246 Possible Orthologues:

Glutamate Receptor 1-Like

Ensembl ID : ENSSTUG00000002642
Gene Symbol: LOC115148454
3 Cross references
242 Possible Orthologues:

Glutamate Receptor 1-Like

Ensembl ID : ENSSTUG00000026827
Gene Symbol: LOC115153917
3 Cross references
243 Possible Orthologues:

Glutamate Receptor 1-Like

Ensembl ID : ENSSTUG00000003607
Gene Symbol: LOC115168483
3 Cross references
244 Possible Orthologues:

Glutamate Receptor 2

Ensembl ID : ENSSTUG00000017349
Gene Symbol: LOC115205107
3 Cross references
219 Possible Orthologues:

Glutamate Receptor 2-Like

Ensembl ID : ENSSTUG00000036143
Gene Symbol: LOC115183661
3 Cross references
236 Possible Orthologues:

Glutamate Receptor 2-Like

Ensembl ID : ENSSTUG00000029830
Gene Symbol: LOC115170654
3 Cross references
220 Possible Orthologues:

Glutamate Receptor 2-Like

Ensembl ID : ENSSTUG00000035975
Gene Symbol: LOC115183660
3 Cross references
236 Possible Orthologues:

Glutamate Receptor 3

Ensembl ID : ENSSTUG00000004859
Gene Symbol: LOC115154457
3 Cross references
245 Possible Orthologues:

Glutamate Receptor 3-Like

Ensembl ID : ENSSTUG00000004925
Gene Symbol: LOC115148999
3 Cross references
245 Possible Orthologues:

Glutamate Receptor 4

Ensembl ID : ENSSTUG00000010114
Gene Symbol: LOC115148623
3 Cross references
244 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).